What Researchers Did
Researchers reviewed 14 controlled trials on hyperbaric oxygen therapy for multiple sclerosis, assessing their methodology and results.
What They Found
Out of 14 controlled trials, eight were considered of reasonable to high quality. Only one of these eight trials showed results favoring hyperbaric oxygen treatment, while the others found no clear positive effects.
What This Means for Canadian Patients
Canadian patients with multiple sclerosis should be aware that current evidence does not support the use of hyperbaric oxygen therapy. Based on this review, hyperbaric oxygen is not recommended as a treatment option for multiple sclerosis.
Canadian Relevance
This review has no specific Canadian connection.
Study Limitations
The review's findings are limited by the quality and heterogeneity of the primary studies available for analysis.